Search results
Results from the WOW.Com Content Network
In an unknown fashion, the antibiotic ristocetin causes von Willebrand factor to bind the platelet receptor glycoprotein Ib (GpIb), so when ristocetin is added to normal blood, it causes agglutination of fixed platelets or initiates the initial agglutination phase of aggregation of live platelets. [citation needed]
If the Col/ADP result is normal (<120 seconds), aspirin-induced platelet dysfunction is most likely. Prolongation of both test results (Col/Epi >180 seconds, Col/ADP >120 seconds) may indicate the following; Anemia (hematocrit <0.28) Thrombocytopenia (platelet count < 100 x 10 9 /L) A significant platelet function defect other than aspirin
The test is then started, and platelet aggregation is recorded at approximately 0.5 second intervals for six minutes. Three parameters are calculated: aggregation, velocity and area under the curve (AUC). Aggregation (in AU) is the maximum height of the aggregation curve, and velocity (in AU/min) is the maximum slope of the curve.
Bleeding time is a medical test done to assess the function of a person's platelets. It involves making a patient bleed, then timing how long it takes for them to stop bleeding using a stopwatch or other suitable devices. The term template bleeding time is used when the test is performed to standardized parameters.
Thromboelastography (TEG) is a method of testing the efficiency of blood coagulation.It is a test mainly used in surgery and anesthesiology, although increasingly used in resuscitations in emergency departments, intensive care units, and labor and delivery suites.
Platelet-Poor Plasma (PPP) is blood plasma with very low number of platelets (< 10 X 10 3 /μL). Traditionally, PPP was recommended for use in platelet aggregation studies to both adjust the platelet-rich plasma concentration, and to serve as a control. [ 1 ]
The normal process of blood clot formation involves the coordinated operation of two separate pathways that feed into a final common pathway: 1) primary hemostasis, i.e. the adhesion, activation, and aggregation of circulating blood platelets at sites of vascular injury and 2) secondary hemostasis, i.e. cleavage of the Aα and Bβ chains of ...
platelet count; bleeding time for platelet function; PR (prothrombin ratio) for the tissue factor pathway (extrinsic pathway) aPTT (Activated Partial Thromboplastin time) for the contact activation pathway (intrinsic pathway) TCT or fibrinogen assay for final common pathway (THROMBIN TIME) Two other tests are regularly performed at the same time: